HCT Cash-Only INcentive to Promote Mealtime Insulin DOSE Engagement
NCT04621890 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 39
Last updated 2025-07-25
Summary
Type 1 Diabetes (T1D) is a serious disease that happens because the body cannot control blood glucose (sugar) levels. People with T1D need insulin shots because their body does not make insulin. Insulin lowers blood sugar levels. When blood sugar levels are too high or too low it causes medical problems.
Youth with T1D can really impact their own health if they follow their T1D treatment plan. However, even with the help of doctors, nurses, and family, most adolescents find it hard to follow their diabetes plan close enough to meet their A1C goal. It is very common for adolescents to forget to give an insulin bolus for meals. When insulin doses are missed, there is a greater chance for poor blood sugar control. When adolescents follow their diabetes plan closely, they have better blood sugar control and overall health.
Two behavioral economic interventions will be evaluated. COIN2DOSE (Cash-Only INcentive to promote mealtime insulin DOSE Engagement) and LOAN2DOSE (Behavioral Economic concept that uses an economic loss aversion approach to promote insulin dose engagement in adolescents with Type 1 Diabetes). These programs were designed to improve blood sugar control by decreasing the number of missed mealtime boluses. For COIN2DOSE, we will offer the opportunity for youth to earn a bonus reimbursement during which they achieve at least 5 days of 3 mealtime insulin boluses. Finally, we will pay youth up for sharing their insulin use data at least two times per week with the study team during the three-month treatment phase. For LOAN2DOSE, the participants will start with a monetary "balance" and will keep it if they bolus as instructed - at least 5 days of 3 mealtime insulin boluses. If they do not do this, their balance will decrease throughout the study.
Conditions
Interventions
- BEHAVIORAL
-
LOAN2DOSE and COIN2DOSE
This is a behavioral economics intervention designed to help improve meal time bolusing behaviors in youth with type 1 diabetes.
Sponsors & Collaborators
-
Children's Mercy Hospital Kansas City
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 12 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-02-14
- Primary Completion
- 2025-06-30
- Completion
- 2025-06-30
Countries
- United States
Study Locations
More Related Trials
-
Adherence Intervention to Promote Optimal Use of Insulin Pumps in Adolescents With Type 1 Diabetes
NCT02333539 ·Status: COMPLETED ·Phase: NA
-
Insulin Clamp Ancillary Study for Assessment of Insulin Resistance
NCT02045290 ·Status: COMPLETED ·Phase: PHASE3
-
Continuous Glucose Monitoring in Adolescents With Poorly Controlled Type 1 Diabetes
NCT01586065 ·Status: COMPLETED ·Phase: NA
-
Closed-Loop Insulin Delivery in Children Less Than 7 Years of Age
NCT01421225 ·Status: COMPLETED ·Phase: NA
-
Lunch Time Insulin Injection by School Nurse for Poorly Controlled Diabetes
NCT00340613 ·Status: COMPLETED ·Phase: PHASE4
-
Expanding Coverage of Continuous Subcutaneous Insulin Infusion in Pediatric Patients With Diabetes
NCT00829062 ·Status: WITHDRAWN ·Phase: NA
-
Flexible, Intensive Insulin Therapy in Patients With Type 1 Diabetes
NCT00595569 ·Status: COMPLETED
-
Real-time Adaptation to Changes in Insulin Sensitivity
NCT01261052 ·Status: COMPLETED ·Phase: PHASE2
-
Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus
NCT00419562 ·Status: COMPLETED ·Phase: PHASE3
-
Sleep Coach for Adolescents With Type 1 Diabetes
NCT06516614 ·Status: RECRUITING ·Phase: NA
-
Timing of Pre-meal Insulin Versus Accurate Carbohydrate Counting in Youth With Type 1 Diabetes
NCT01209312 ·Status: COMPLETED ·Phase: NA
-
Arterial Stiffness in Type I Diabetes Mellitus
NCT02218268 ·Status: COMPLETED
-
Clinical Usability of Nasal Glucagon in Treatment of Hypoglycemia in Children and Adolescents
NCT02402933 ·Status: COMPLETED ·Phase: PHASE3
-
Risk Factors of Metabolic Control in Children and Adolescents With Type 1 Diabetes
NCT03642470 ·Status: COMPLETED
-
CGM Intervention in Teens and Young Adults With Type 1 Diabetes (T1D)
NCT03263494 ·Status: COMPLETED ·Phase: PHASE3
-
Exercise Snacks and Glutamine to Improve Glucose Control in Adolescents With Type 1 Diabetes
NCT03199638 ·Status: COMPLETED ·Phase: NA
-
Investigating the Pharmacokinetics and Pharmacodynamics of Recombinant Human Insulin Administered by Dry Powder Inhaler
NCT00426920 ·Status: UNKNOWN ·Phase: PHASE1
-
Diluted Insulin in Young Children: Bigger Volumes for Smaller Patients
NCT03666065 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Simple Meal Management Using Automated Insulin Delivery System
NCT06130215 ·Status: RECRUITING ·Phase: NA
-
Evaluation of an Early Screener to Identify Long-term Problems With Regard to Metabolic Control and Treatment Adherence Among Children and Adolescents With Type 1 Diabetes
NCT03642483 ·Status: COMPLETED
-
Evaluation of Gut Absorption Rate of Glucose After a Large Evening Meal in Type 1 Diabetes
NCT02782195 ·Status: COMPLETED
-
The Effect of Insulin During Exercise on the Development of Low Blood Sugar in Individuals With Type I Diabetes
NCT00147342 ·Status: COMPLETED
-
Sensor-Augmented Insulin Delivery: Insulin Plus Glucagon Versus Insulin Alone
NCT00797823 ·Status: COMPLETED ·Phase: PHASE2
-
Time Limited Eating in Type 1 Diabetes
NCT05031429 ·Status: COMPLETED ·Phase: NA
-
A Study of Glucose Control in Participants With Type 1 and Type 2 Diabetes
NCT04667182 ·Status: WITHDRAWN